ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, cilt.27, sa.3, ss.121-126, 2018 (ESCI)
Introduction: This study used real-world data to evaluate the effectiveness and reliability of omalizumab in treating recalcitrant chronic spontaneous urticaria in Turkish patients.